Review of vascularized bone marrow transplantation: Current status and future clinical applications

In this review, we examine the applicability of the vascularized bone marrow transplant (VBMT) as an alternative to conventional bone marrow transplantation (BMT). As a new surgical approach, the VBMT is unique by transplantation of the stromal environment that eliminates the need for an engraftment...

Full description

Saved in:
Bibliographic Details
Published inMicrosurgery Vol. 27; no. 4; pp. 348 - 353
Main Authors Gordon, Chad R., Tai, Chau Y., Suzuki, Hidetoshi, Strande, Louise F., Ramsamooj, Rajendra, Matthews, Martha S., Black, Kirby S., Hewitt, Charles W.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In this review, we examine the applicability of the vascularized bone marrow transplant (VBMT) as an alternative to conventional bone marrow transplantation (BMT). As a new surgical approach, the VBMT is unique by transplantation of the stromal environment that eliminates the need for an engraftment period, provides critical signaling and modulatory functions, and may potentiate tolerance induction. Thus far, VBMT studies have demonstrated an absence of graft‐versus‐host disease (GVHD) and robust engraftment into nonmanipulated as well as irradiated recipients with evidence of immunological tolerance. Further investigation is needed to determine the applicability of VBMT as an alternative to BMT. © 2007 Wiley‐Liss, Inc. Microsurgery 2007.
Bibliography:istex:C7D88D18A469A680D923D4BB8489A9726FA1846F
American Heart Association (Heritage Affiliate Grant) - No. 0555795T
ark:/67375/WNG-D0N35DVW-T
ArticleID:MICR20367
Dr. Hewitt is the American Heart Association Ellen Marmer Research Fellow.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0738-1085
1098-2752
DOI:10.1002/micr.20367